ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 35 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,000 | – | 3,727 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,498,192 | $1,678,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 2,054,925 | $2,302,000 | 0.46% |
| Sio Capital Management, LLC | 1,270,758 | $1,423,000 | 0.43% |
| DAFNA Capital Management LLC | 732,500 | $820,000 | 0.21% |
| Vivo Capital, LLC | 2,840,909 | $3,182,000 | 0.19% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $2,816,000 | 0.17% |
| SABBY MANAGEMENT, LLC | 899,850 | $1,008,000 | 0.15% |
| Waterfront Wealth Inc. | 270,000 | $302,000 | 0.12% |
| Knott David M Jr | 230,251 | $258,000 | 0.09% |
| RTW INVESTMENTS, LP | 3,250,000 | $3,640,000 | 0.05% |